Clinical Trial Update: Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types [Phase 2, Phase 3]

View source ↗

Summary

A multicenter validation trial evaluating the PET imaging agent [18F]AlF-FAPI-74 to visualize cancer-associated fibroblasts across esophageal, gastric, and panc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• [18F]AlF-FAPI-74 (FAPI-74 radiopharmaceutical labeled with Fluorine-18 via Aluminum-Fluoride complex)

Snippet

Sponsor: KU Leuven | Conditions: Oesophageal Cancer, Gastric Cancer | Phase 2, Phase 3 | Status: RECRUITING